Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · January 09, 2023

Tralokinumab Treatment Improves the Skin Microbiota by Increasing the Microbial Diversity in Adults With Moderate to Severe Atopic Dermatitis

Journal of the American Academy of Dermatology


Additional Info

Journal of the American Academy of Dermatology
Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial
J Am Acad Dermatol 2022 Dec 05;[EPub Ahead of Print], LA Beck, T Bieber, S Weidinger, M Tauber, H Saeki, AD Irvine, LF Eichenfield, T Werfel, P Arlert, L Jiang, M Røpke, AS Paller

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading